blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3615026

EP3615026 - A PARP INHIBITOR IN COMBINATION WITH A GLUCOCORTICOID AND/OR ASCORBIC ACID AND/OR A PROTEIN GROWTH FACTOR FOR THE TREATMENT OF IMPAIRED WOUND HEALING [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.01.2022
Database last updated on 12.11.2024
FormerThe patent has been granted
Status updated on  29.01.2021
FormerGrant of patent is intended
Status updated on  14.09.2020
FormerRequest for examination was made
Status updated on  31.01.2020
FormerThe international publication has been made
Status updated on  02.11.2018
Formerunknown
Status updated on  14.05.2018
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
Akribes Biomedical GmbH
Dr.-Bohr-Gasse 7
1030 Wien / AT
[2021/09]
Former [2020/10]For all designated states
Akribes Biomedical GmbH
Campus Vienna Biocenter 5
1030 Wien / AT
Inventor(s)01 / WOLFF-WINISKI, Barbara
Maurer Lange Gasse 137/9
1230 Wien / AT
02 / STÜTZ, Anton
Teichweg 4
4813 Altmünster / AT
03 / DÖRFLER, Petra
Dr. Julius Wengraf-Strasse 22
2345 Brunn am Gebirge / AT
 [2020/10]
Representative(s)Pintsch, Tanja
Patentanwälte Isenbruck Bösl Hörschler PartG mbB
Prinzregentenstraße 68
81675 München / DE
[2020/10]
Application number, filing date18721012.524.04.2018
[2020/10]
WO2018EP60429
Priority number, dateEP2017000074228.04.2017         Original published format: EP 17000742
[2020/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018197461
Date:01.11.2018
Language:EN
[2018/44]
Type: A1 Application with search report 
No.:EP3615026
Date:04.03.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 01.11.2018 takes the place of the publication of the European patent application.
[2020/10]
Type: B1 Patent specification 
No.:EP3615026
Date:03.03.2021
Language:EN
[2021/09]
Search report(s)International search report - published on:EP01.11.2018
ClassificationIPC:A61K31/4184, A61K31/519, A61K31/517, A61K31/55, A61K31/166, A61K31/473, A61P17/02
[2020/10]
CPC:
A61P17/02 (EP,US); A61K31/375 (EP,US); A61K31/166 (EP);
A61K31/4184 (EP); A61K31/454 (EP); A61K31/473 (EP);
A61K31/501 (EP); A61K31/5025 (EP); A61K31/517 (EP);
A61K31/519 (EP); A61K31/55 (EP); A61K31/5517 (EP);
A61K31/57 (EP); A61K31/573 (US); A61K31/661 (EP);
A61K38/18 (EP,US); A61K45/06 (EP,US) (-)
C-Set:
A61K31/166, A61K2300/00 (EP);
A61K31/375, A61K2300/00 (EP);
A61K31/4184, A61K2300/00 (EP);
A61K31/454, A61K2300/00 (EP);
A61K31/473, A61K2300/00 (EP);
A61K31/501, A61K2300/00 (EP);
A61K31/5025, A61K2300/00 (EP);
A61K31/517, A61K2300/00 (EP);
A61K31/519, A61K2300/00 (EP);
A61K31/5517, A61K2300/00 (EP);
A61K31/55, A61K2300/00 (EP);
A61K31/57, A61K2300/00 (EP);
A61K31/661, A61K2300/00 (EP);
A61K38/18, A61K2300/00 (EP)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/10]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:EIN PARP-HEMMER IN KOMBINATION MIT EINEM GLUCOCORTICOID UND/ODER ASCORBINSÄURE UND/ODER EINEM PROTEINWACHSTUMSFAKTOR ZUR BEHANDLUNG VON GESTÖRTER WUNDHEILUNG[2020/37]
English:A PARP INHIBITOR IN COMBINATION WITH A GLUCOCORTICOID AND/OR ASCORBIC ACID AND/OR A PROTEIN GROWTH FACTOR FOR THE TREATMENT OF IMPAIRED WOUND HEALING[2020/10]
French:UN INHIBITEUR DE PARP EN COMBINAISON AVEC UN GLUCOCORTICOÏDE ET/OU DE L'ACIDE ASCORBIQUE ET/OU UN FACTEUR DE CROISSANCE DE PROTÉINES POUR TRAITER DES TROUBLES DE LA CICATRISATION DE PLAIES[2020/37]
Former [2020/10]PARP-INHIBITOR IN KOMBINATION MIT EINEM GLUCOCORTICOID- UND/ODER ASCORBINSÄURE- UND/ODER PROTEINWACHSTUMSFAKTOR ZUR BEHANDLUNG VON GESTÖRTER WUNDHEILUNG
Former [2020/10]INHIBITEUR DE PARP EN COMBINAISON AVEC UN GLUCOCORTICOÏDE ET/OU L'ACIDE ASCORBIQUE ET/OU UN FACTEUR DE CROISSANCE DE PROTÉINE POUR LE TRAITEMENT D'UNE MAUVAISE CICATRISATION DE PLAIE
Entry into regional phase12.11.2019National basic fee paid 
12.11.2019Designation fee(s) paid 
12.11.2019Examination fee paid 
Examination procedure12.11.2019Examination requested  [2020/10]
12.11.2019Date on which the examining division has become responsible
27.05.2020Amendment by applicant (claims and/or description)
15.09.2020Communication of intention to grant the patent
21.01.2021Fee for grant paid
21.01.2021Fee for publishing/printing paid
21.01.2021Receipt of the translation of the claim(s)
Opposition(s)06.12.2021No opposition filed within time limit [2022/06]
Fees paidRenewal fee
23.03.2020Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.04.2018
AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
ES03.03.2021
FI03.03.2021
HR03.03.2021
IT03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
MK03.03.2021
MT03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
IE24.04.2021
LU24.04.2021
BE30.04.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
[2024/42]
Former [2024/23]HU24.04.2018
AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
ES03.03.2021
FI03.03.2021
HR03.03.2021
IT03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
MK03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
IE24.04.2021
LU24.04.2021
BE30.04.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2023/33]HU24.04.2018
AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
ES03.03.2021
FI03.03.2021
HR03.03.2021
IT03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
IE24.04.2021
LU24.04.2021
BE30.04.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2023/30]AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
ES03.03.2021
FI03.03.2021
HR03.03.2021
IT03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
IE24.04.2021
LU24.04.2021
BE30.04.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2022/34]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
ES03.03.2021
FI03.03.2021
HR03.03.2021
IT03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
IE24.04.2021
LU24.04.2021
BE30.04.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2022/23]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
ES03.03.2021
FI03.03.2021
HR03.03.2021
IT03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
IE24.04.2021
LU24.04.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2022/21]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
ES03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
IE24.04.2021
LU24.04.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
PT05.07.2021
Former [2022/13]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
ES03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
LU24.04.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
PT05.07.2021
Former [2022/10]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
ES03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SK03.03.2021
SM03.03.2021
LU24.04.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
PT05.07.2021
Former [2022/08]AL03.03.2021
AT03.03.2021
CZ03.03.2021
DK03.03.2021
EE03.03.2021
ES03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SK03.03.2021
SM03.03.2021
LU24.04.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2022/07]AL03.03.2021
AT03.03.2021
CZ03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SK03.03.2021
SM03.03.2021
LU24.04.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2022/04]AT03.03.2021
CZ03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SK03.03.2021
SM03.03.2021
LU24.04.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2021/51]AT03.03.2021
CZ03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2021/50]AT03.03.2021
CZ03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
NL03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SE03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
PT05.07.2021
Former [2021/48]AT03.03.2021
CZ03.03.2021
EE03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
NL03.03.2021
PL03.03.2021
RS03.03.2021
SE03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/46]AT03.03.2021
FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
NL03.03.2021
PL03.03.2021
RS03.03.2021
SE03.03.2021
SM03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/43]FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
NL03.03.2021
PL03.03.2021
RS03.03.2021
SE03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/39]FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
PL03.03.2021
RS03.03.2021
SE03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/38]FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
RS03.03.2021
SE03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/37]FI03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
RS03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/36]FI03.03.2021
HR03.03.2021
LT03.03.2021
BG03.06.2021
NO03.06.2021
GR04.06.2021
Former [2021/35]FI03.03.2021
HR03.03.2021
LT03.03.2021
NO03.06.2021
Former [2021/33]FI03.03.2021
LT03.03.2021
NO03.06.2021
Cited inInternational search[AD]  - ZHOU XIN ET AL, "Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis", JOURNAL OF VASCULAR SURGERY, (20160608), vol. 65, no. 4, doi:10.1016/J.JVS.2016.03.407, ISSN 0741-5214, pages 1161 - 1169, XP085097852 [AD] 1-15 * the whole document * * Abstract, Discussion, Conclusions *

DOI:   http://dx.doi.org/10.1016/j.jvs.2016.03.407
 [AD]  - TAREK EL-HAMOLY ET AL, "3-aminobenzamide, a poly (ADP ribose) polymerase inhibitor, enhances wound healing in whole body gamma irradiated model : PARP inhibition & gamma irradiated wounds", WOUND REPAIR AND REGENERATION., (2015), vol. 23, no. 5, doi:10.1111/wrr.12330, ISSN 1067-1927, pages 672 - 684, XP055414446 [AD] 1-15 * the whole document * * Abstract, Discussion *

DOI:   http://dx.doi.org/10.1111/wrr.12330
 [AD]  - HENGGE ET AL, "Adverse effects of topical glucocorticosteroids", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, (2006), vol. 54, no. 1, doi:10.1016/J.JAAD.2005.01.010, ISSN 0190-9622, pages 1 - 15, XP005219461 [AD] 1-15 * the whole document * * Abstract, Conclusions, Delayed wound healing (page 8, right-hand column, last paragraph) *

DOI:   http://dx.doi.org/10.1016/j.jaad.2005.01.010
by applicantUS5283173
 WO9524379
 US5468614
 US5587384
 WO0112199
 WO0116136
 WO0121615
 WO0123390
 WO0142219
 WO0157038
 WO0179184
 WO0185687
 WO0185686
 WO0190077
 WO0236599
 US6426415
 WO02068407
 US6476048
 WO02094790
 WO03007959
 US6514983
 WO03051879
 WO03055865
 WO03057145
 WO03070707
 WO03080581
 US6635642
 WO2004014873
 WO2004024694
 WO2004043959
 WO2004048339
 WO2004087713
 WO2004096793
 WO2004096779
 US2004229895
 WO2004105700
 WO2004108723
 WO2005012305
 US2005054631
 WO2005054210
 WO2005054209
 WO2005054201
 WO2005058843
 WO2005097750
 WO2005123687
 WO2006003150
 WO2006003148
 WO2006003147
 WO2006003146
 WO2006024545
 WO2006042638
 WO2006078503
 WO2006078711
 WO2009004356
 WO2009093032
    - GOTTRUP F, Am J Surg, (20040000), vol. 187, pages 38S - 43S
    - DISSEMOND J et al., JDDG, (20140000), pages 541 - 554
    - HENGGE UR, J Am Acad Dermatol, (20060000), vol. 54, pages 1 - 15
    - FARKAS B et al., "Reduction of acute photodamage in skin by topical application of a novel PARP inhibitor", Biochem Pharmacol, (20020000), vol. 63, pages 921 - 932
    - BYUN Y-S et al., "Poly(ADP-ribose) polymerase inhibition improves corneal epithelial innervation and wound healing in diabetic rats", Invest Ophthalmol Vis Sci, (20150000), vol. 56, pages 1948 - 1955
    - EL-HAMOLY T et al., "3-aminobenzaminde, a poly (ADP ribose) polymerase inhibitor, enhances wound healing in whole body gamma irradiated model", Wound Rep Reg, (20150000), vol. 23, doi:doi:10.1111/wrr.12330, pages 672 - 684, XP055414446

DOI:   http://dx.doi.org/10.1111/wrr.12330
    - EL-HAMOLY T et al., "Activation of poly (ADP ribose) polymerase-1 delays wound healing by regulating keratinocyte migration and production of inflammatory mediators", Mol Med, (20140000), vol. 20, pages 363 - 371
    - SARRAS MP, "Inhibition of poly-APD ribose polymerase enzyme activitiy prevents hyperglycemia-induced impairment of angiogenesis during wound healing", Wound Rep Reg, (20140000), vol. 22, pages 666 - 670
    - VIRAG L; SZABO C, "The therapeutic potential of poly (ADP ribose) polymerase inhibitors", Pharmacol Rev, (20020000), vol. 54, doi:doi:10.1124/pr.54.3.375, pages 375 - 429, XP002478275

DOI:   http://dx.doi.org/10.1124/pr.54.3.375
    - ASMUSSEN S et al., "The angiotensin-converting enzyme inhibitor captopril inhibits poly(ADP-ribose)polymerase activation and exerts beneficial effects in an ovine model of burn and smoke injury", Shock, (20110000), vol. 3, pages 402 - 409
    - THORSELL AG, "Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors", J Med Chem, (20160000), vol. 59, pages 335 - 357
    - ZHOU X et al., "Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis", J Vasc Surg, (20170000), vol. 65, pages 1161 - 1169
    - PENNING, Current Opinion In Drug Discovery & Development, (20100000), vol. 13, no. 5, pages 577 - 586
    - ANDRABI SA et al., Proc Natl Acad Sci USA., (20060000), vol. 103, no. 48, pages 18308 - 13
    - AFFAR EB et al., Anal Biochem., (19980000), vol. 259, no. 2, pages 280 - 3
    - K.J. DILLON et al., Journal of Biomolecular Screening, (20030000), vol. 8, no. 3, pages 347 - 352
    - BANASIK et al., J. Biol. Chem., (19920000), vol. 267, no. 3, pages 1569 - 75
    - BANASIK et al., Molec. Cell. Biochem., (19940000), vol. 138, pages 185 - 97
    - COSI, Expert Opin. Ther. Patents, (20020000), vol. 12, no. 7
    - SOUTHAN; SZABO, Curr Med Chem, (20030000), vol. 10, pages 321 - 340
    - SCOUTEN, W. H., Methods in Enzymology, (19870000), vol. 135, pages 30 - 65
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.